Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Phase NA × Unknown × Platinum Compounds × Clear all

Phase

Phase 2 7 Phase NA 1 Phase 1 1

Status

Unknown 1 Recruiting 1 Enrolling by invitation 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Neoplasms 1 Lung Neoplasms 1

Interventions

Exercise 56 Radiotherapy 49 Blood Specimen Collection 48 Radiosurgery 36 Standard of Care 32 Drug Therapy 32 Surgical Procedures, Operative 30 Magnetic Resonance Spectroscopy 26 Cisplatin 24 Biopsy 24 Acupuncture Therapy 24 Laparoscopy 23 Cyclophosphamide 23 Magnetic Resonance Imaging 20 Radiofrequency Ablation 19 Endoscopic Mucosal Resection 19 Control Groups 19 Saline Solution 18 camrelizumab 16 Propofol 16 Metformin 16 Cytarabine 16 Surveys and Questionnaires 15 Preoperative Exercise 15 Injections 15 Fluorouracil 15 anlotinib 14 Radiotherapy, Intensity-Modulated 14 Neoadjuvant Therapy 14 Early Intervention, Educational 14

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT06000358 2023-08-21

LUCACRIMUNO

Lithuanian University of Health Sciences

Phase NA Unknown

Lung Neoplasms, Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡